Drug Trial Begins Targeting Mitochondrial Diseases

Print Friendly, PDF & Email

Exclusive Interview with Dr. Guy Miller, CEO of Edison Pharma.

Is there hope for a cure for Mitochondrial Disease? Perhaps the answer is closer than we thought.

On July 15, 2008 Edison Pharma and partner Penwest Pharmaceuticals announced that A0001, an “improved” variant of Coenzyme Q10 (CoQ10), has entered Phase 1 clinical development with healthy volunteers. Edison predicts trials in patients with inherited mitochondrial disease will begin in 2009.

Date: 07/15/2008
Listen Now: Click Here

Related Articles

MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Date: 03/18/2022

Dr. Jan Smeitink

The Mito Disease Drug Development Journey
Date: 12/01/2021

Dr. Matthew Klein

Moving Mito Medicine: Reneo Strides Study
Date: 06/04/2021

Madhu Davies